These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33022385)

  • 1. Interatrial shunt devices for the treatment of heart failure.
    Emani S; Burkhoff D; Lilly SM
    Trends Cardiovasc Med; 2021 Oct; 31(7):427-432. PubMed ID: 33022385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creation of a restrictive atrial left-to-right shunt: a novel treatment for heart failure.
    De Rosa R; Schranz D
    Heart Fail Rev; 2018 Nov; 23(6):841-847. PubMed ID: 30267205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.
    Feldman T; Mauri L; Kahwash R; Litwin S; Ricciardi MJ; van der Harst P; Penicka M; Fail PS; Kaye DM; Petrie MC; Basuray A; Hummel SL; Forde-McLean R; Nielsen CD; Lilly S; Massaro JM; Burkhoff D; Shah SJ;
    Circulation; 2018 Jan; 137(4):364-375. PubMed ID: 29142012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interatrial Shunt Devices.
    Salah HM; Baratto C; Yaranov DM; Rommel KP; Achanta S; Caravita S; Reddy Vasanthu VK; Fudim M
    Heart Fail Clin; 2024 Jan; 20(1):61-69. PubMed ID: 37953022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction.
    Kaye DM; Petrie MC; McKenzie S; Hasenfuβ G; Malek F; Post M; Doughty RN; Trochu JN; Gustafsson F; Lang I; Kolodziej A; Westenfeld R; Penicka M; Rosenberg M; Hausleiter J; Raake P; Jondeau G; Bergmann MW; Spelman T; Aytug H; Ponikowski P; Hayward C;
    ESC Heart Fail; 2019 Feb; 6(1):62-69. PubMed ID: 30311437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure: Rationale and Design of the Randomized Trial to REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I).
    Feldman T; Komtebedde J; Burkhoff D; Massaro J; Maurer MS; Leon MB; Kaye D; Silvestry FE; Cleland JG; Kitzman D; Kubo SH; Van Veldhuisen DJ; Kleber F; Trochu JN; Auricchio A; Gustafsson F; Hasenfuβ G; Ponikowski P; Filippatos G; Mauri L; Shah SJ
    Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27330010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous Atriotomy for Levoatrial-to-Coronary Sinus Shunting in Symptomatic Heart Failure: First-in-Human Experience.
    Simard T; Labinaz M; Zahr F; Nazer B; Gray W; Hermiller J; Chaudhry SP; Guimaraes L; Philippon F; Eckman P; Rodés-Cabau J; Sorajja P; Hibbert B
    JACC Cardiovasc Interv; 2020 May; 13(10):1236-1247. PubMed ID: 32438996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and Design of the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (Reduce LAP-HF) Trial.
    Hasenfuss G; Gustafsson F; Kaye D; Shah SJ; Burkhoff D; Reymond MC; Komtebedde J; Hünlich M;
    J Card Fail; 2015 Jul; 21(7):594-600. PubMed ID: 26055211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. InterAtrial Shunt Device (IASD®) implantation - a novel treatment method for heart failure with preserved ejection fraction.
    Kosowski M; Kübler P; Kołodziej A; Krakowiak B; Kustrzycka-Kratochwil D; Sławin J; Sokolski M; Biegus J; Zymliński R; Banasiak W; Ponikowski P; Reczuch K
    Kardiol Pol; 2017; 75(8):736-741. PubMed ID: 28541594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left atrial decompression through unidirectional left-to-right interatrial shunt for the treatment of left heart failure: first-in-man experience with the V-Wave device.
    Amat-Santos IJ; Bergeron S; Bernier M; Allende R; Barbosa Ribeiro H; Urena M; Pibarot P; Verheye S; Keren G; Yaacoby M; Nitzan Y; Abraham WT; Rodés-Cabau J
    EuroIntervention; 2015 Jan; 10(9):1127-31. PubMed ID: 24832489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel interatrial implant to lower left atrial pressure.
    Søndergaard L; Reddy V; Kaye D; Malek F; Walton A; Mates M; Franzen O; Neuzil P; Ihlemann N; Gustafsson F
    Eur J Heart Fail; 2014 Jul; 16(7):796-801. PubMed ID: 24961390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction.
    Nanayakkara S; Kaye DM
    Heart Fail Rev; 2023 Mar; 28(2):281-286. PubMed ID: 35438418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interatrial Stent to Treat Stiff Left Atrium Syndrome.
    Zaidi D; Williams D; Zhao D; Upadhya B; Gilbert O
    Cardiovasc Revasc Med; 2022 Jul; 40S():337-340. PubMed ID: 35105508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Baseline Hemodynamics on the Effects of a Transcatheter Interatrial Shunt Device in Heart Failure With Preserved Ejection Fraction.
    Wessler J; Kaye D; Gustafsson F; Petrie MC; Hasenfuβ G; Lam CSP; Borlaug BA; Komtebedde J; Feldman T; Shah SJ; Burkhoff D;
    Circ Heart Fail; 2018 Aug; 11(8):e004540. PubMed ID: 30354556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State-of-the-Art Review of Current Therapies for HFpEF: An Overview of Interatrial Septal Device Therapy in Heart Failure.
    Al-Sadawi M; Ortega RR; Ariyaratnam J; Battisha A; Madoukh B; Bukharovich I
    Curr Cardiol Rev; 2021; 17(5):e230421189012. PubMed ID: 33305708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review.
    Burlacu A; Simion P; Nistor I; Covic A; Tinica G
    Heart Fail Rev; 2019 Sep; 24(5):793-803. PubMed ID: 30949860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [InterAtrial Shunt Device in diastolic heart failure].
    Hasenfuß G; Jacobshagen C
    Internist (Berl); 2018 Oct; 59(10):1054-1062. PubMed ID: 30194481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure With Preserved Ejection Fraction.
    Kaye DM; Hasenfuß G; Neuzil P; Post MC; Doughty R; Trochu JN; Kolodziej A; Westenfeld R; Penicka M; Rosenberg M; Walton A; Muller D; Walters D; Hausleiter J; Raake P; Petrie MC; Bergmann M; Jondeau G; Feldman T; Veldhuisen DJ; Ponikowski P; Silvestry FE; Burkhoff D; Hayward C
    Circ Heart Fail; 2016 Dec; 9(12):e003662. PubMed ID: 27852653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial flow regulator as a novel therapy for patients with chronic heart failure.
    Lewicki Ł; Sabiniewicz R; Siebert J; Szołkiewicz M
    Cardiol J; 2020; 27(3):309-311. PubMed ID: 32436584
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment With an Interatrial Shunt in Heart Failure: 1-Year Outcomes of the PRELIEVE Study.
    Paitazoglou C; Bergmann MW; Kilicaslan B; Kilic T; Bartunek J; Pfister R; Iliadis C; Kaya EB; Ozdemir R
    JACC Heart Fail; 2024 Mar; 12(3):591-594. PubMed ID: 38180430
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.